Liwanli Innovation Co (TPE:3054) Research & Development: NT$9.8 Mil (TTM As of Dec. 2025)


TPE:3054 Liwanli Innovation Co Ltd TPE:3054
61 GF Score
Price NT$61.60
GF Value NT$39.71
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Liwanli Innovation Co Research & Development?

Liwanli Innovation Co TPE:3054 -6.10% 61 Research & Development is NT$9.8 Mil as of Dec. 2025. GuruFocus rates TPE:3054 with a GF Score™ of 61/100 and a GF Value™ of NT$39.71 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Liwanli Innovation Co's Research & Development for the three months ended in Dec. 2025 was NT$5.4 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$9.8 Mil.

Liwanli Innovation Co  (TPE:3054) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Liwanli Innovation Co Research & Development Related Terms

Liwanli Innovation Co Research & Development Historical Data

* Premium members only.

The historical data trend for Liwanli Innovation Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Liwanli Innovation Co Research & Development Chart

Liwanli Innovation Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.09 0.01 0.00 9.81

Liwanli Innovation Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.52 1.34 1.52 5.43
TPE:3054
61GF Score
Liwanli Innovation Co Ltd TPE:3054
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Liwanli Innovation Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$9.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$9.8 Mil mean?
Liwanli Innovation Co (TPE:3054) has a Research & Development of NT$9.8 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Liwanli Innovation Co and its competitors.
Is Liwanli Innovation Co's Research & Development too high?
Liwanli Innovation Co's current Research & Development is NT$9.8 Mil. Overall, Liwanli Innovation Co has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Liwanli Innovation Co's Research & Development compare to ZTS?
Liwanli Innovation Co's Research & Development of NT$9.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Liwanli Innovation Co and its competitors. Liwanli Innovation Co's current Research & Development is NT$9.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liwanli Innovation Co stock overvalued right now?
Based on GuruFocus' analysis, Liwanli Innovation Co (TPE:3054) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$39.71, compared to a current price of NT$61.60 — trading 55.1% above its estimated fair value. The current Research & Development is NT$9.8 Mil. Liwanli Innovation Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Liwanli Innovation Co (TPE:3054), the current Research & Development is NT$9.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Liwanli Innovation Co (TPE:3054) Overvalued in 2026?

Based on GuruFocus' analysis, Liwanli Innovation Co stock appears to be overvalued. The current stock price of NT$61.60 is trading 55.1% above its estimated GF Value™ of NT$39.71. GuruFocus considers Liwanli Innovation Co to be Significantly Overvalued.

Key valuation signals for TPE:3054:

  • Research & Development: NT$9.8 Mil
  • GF Value™: NT$39.71 vs. price of NT$61.60 (55.1% above fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the TPE:3054 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Liwanli Innovation Co Business Description

Address No. 537, Tanmei Street, 9th Floor, Neihu District, Taipei City, TWN, 235
Liwanli Innovation Co Ltd is engaged in the manufacture, wholesale, and retail of electronic materials and the sales of biotech products like drug nutrient products. The reportable segments of the company are distinguished by products; the electronic department is mainly engaged in the sale and after-sales service of computer peripherals, memory and other related products; and the biotechnology department is mainly engaged in the sales of biotechnology products. Maximum revenue is generated from its Electronics department. Geographically, it generates a majority of its revenue from Taiwan, followed by other regions.
61GF Score

Get the complete analysis for TPE:3054

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$61.60
Price
NT$39.71
GF Value